Elevance Health Files 8-K on Shareholder Votes

Ticker: ELV · Form: 8-K · Filed: 2025-05-14T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance

TL;DR

Elevance Health shareholders voted on key company matters on May 14, 2025.

AI Summary

Elevance Health, Inc. filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing indicates that the company held a meeting where shareholders voted on various corporate matters. The exact details of the votes and their outcomes are not specified in this summary section of the filing.

Why It Matters

This filing informs investors about important decisions made by Elevance Health's shareholders, which could impact the company's governance and future direction.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of shareholder meeting outcomes and does not indicate any immediate financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Elevance Health's security holders?

The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this section of the 8-K.

When was the date of the shareholder meeting or vote?

The filing indicates the date of the earliest event reported is May 14, 2025.

What is the principal executive office address for Elevance Health?

The principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.

What is Elevance Health's IRS Employer Identification Number?

The IRS Employer Identification Number for Elevance Health is 35-2145715.

Has Elevance Health previously operated under different names?

Yes, Elevance Health was formerly known as Anthem, Inc. (name change effective December 2, 2014), WellPoint, Inc. (name change effective January 5, 2010), and WellPoint Inc. (name change effective November 30, 2004).

From the Filing

0001156039-25-000065.txt : 20250514 0001156039-25-000065.hdr.sgml : 20250514 20250514172734 ACCESSION NUMBER: 0001156039-25-000065 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250514 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250514 DATE AS OF CHANGE: 20250514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 25947262 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 elv-20250514.htm 8-K elv-20250514 FALSE 0001156039 0001156039 2025-05-14 2025-05-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 14, 2025 Date of Report (Date of earliest event reported) ___________________________________ Elevance Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Indiana (State or other jurisdiction of incorporation or organization) 001-16751 (Commission File Number) 35-2145715 (I.R.S. Employer Identification Number) 220 Virginia Ave Indianapolis , IN 46204 (Address of principal executive offices and zip code) ( 833 ) 401-1577 (Registrant's telephone number, including area code) ________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07 - Submission of Matters to a Vote of Security Holders On May 14, 2025, Elevance Health, Inc. (the " Company ") held its Annual Meeting of Shareholders. The shareholders of the Company voted as follows on the matters set forth below. 1. Election of Directors . The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2028 based on the following votes: Nominee For Against Abstain Broker Non-Votes Susan D. DeVore 185,839,586 3,726,860 158,903 11,942,703 Bahija Jallal 180,810,837 8,752,093 162,419 11,942,703 Ryan M. Schneider 184,627,201 4,951,857 146,291 11,942,703 2. Adv

View on Read The Filing